JP2020015742A5 - - Google Patents

Download PDF

Info

Publication number
JP2020015742A5
JP2020015742A5 JP2019155520A JP2019155520A JP2020015742A5 JP 2020015742 A5 JP2020015742 A5 JP 2020015742A5 JP 2019155520 A JP2019155520 A JP 2019155520A JP 2019155520 A JP2019155520 A JP 2019155520A JP 2020015742 A5 JP2020015742 A5 JP 2020015742A5
Authority
JP
Japan
Prior art keywords
composition according
composition
ala
leu
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019155520A
Other languages
English (en)
Japanese (ja)
Other versions
JP6941143B2 (ja
JP2020015742A (ja
Filing date
Publication date
Priority claimed from JP2016550427A external-priority patent/JP6580581B2/ja
Application filed filed Critical
Publication of JP2020015742A publication Critical patent/JP2020015742A/ja
Publication of JP2020015742A5 publication Critical patent/JP2020015742A5/ja
Application granted granted Critical
Publication of JP6941143B2 publication Critical patent/JP6941143B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019155520A 2014-09-27 2019-08-28 注射用医薬組成物 Active JP6941143B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014197667 2014-09-27
JP2014197667 2014-09-27
JP2016550427A JP6580581B2 (ja) 2014-09-27 2015-09-26 注射用医薬組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016550427A Division JP6580581B2 (ja) 2014-09-27 2015-09-26 注射用医薬組成物

Publications (3)

Publication Number Publication Date
JP2020015742A JP2020015742A (ja) 2020-01-30
JP2020015742A5 true JP2020015742A5 (https=) 2020-07-30
JP6941143B2 JP6941143B2 (ja) 2021-09-29

Family

ID=55581312

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016550427A Active JP6580581B2 (ja) 2014-09-27 2015-09-26 注射用医薬組成物
JP2019155520A Active JP6941143B2 (ja) 2014-09-27 2019-08-28 注射用医薬組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016550427A Active JP6580581B2 (ja) 2014-09-27 2015-09-26 注射用医薬組成物

Country Status (8)

Country Link
US (1) US10471136B2 (https=)
EP (1) EP3199175B1 (https=)
JP (2) JP6580581B2 (https=)
CN (1) CN106687129B (https=)
CA (1) CA2962630C (https=)
DK (1) DK3199175T3 (https=)
ES (1) ES2916834T3 (https=)
WO (1) WO2016047797A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
KR102058961B1 (ko) 2018-07-28 2019-12-24 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
EP3849579A4 (en) 2018-09-14 2022-06-15 Cara Therapeutics, Inc. Oral formulations of kappa opioid receptor agonists
JP7162675B2 (ja) * 2018-09-28 2022-10-28 住友ファーマ株式会社 注射用組成物
AU2021236662A1 (en) 2020-03-18 2022-11-10 Cara Therapeutics, Inc. Oligosaccharide formulations of kappa opioid receptor agonists
JP2024149926A (ja) * 2021-08-06 2024-10-23 ブライトパス・バイオ株式会社 がんペプチドワクチンカクテル製剤、及びその製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3895782B2 (ja) * 1992-10-26 2007-03-22 生化学工業株式会社 コンドロイチナーゼ組成物およびそれを含有する注射用製剤
US5496718A (en) 1992-06-26 1996-03-05 Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) Chondroitinase ABC isolated from proteus vulgaris ATCC 6896
AU4932199A (en) 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
JP2000229882A (ja) * 1998-12-10 2000-08-22 Sankyo Co Ltd 修飾シクロデキストリン含有トロンビン水性液剤
EP1371664B1 (en) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti modified peptide
EP1506786B1 (en) 2002-05-21 2016-11-23 Daiichi Sankyo Company, Limited Medicinal compositions containing ghrelin
ES2332590T3 (es) 2003-01-15 2010-02-09 International Institute Of Cancer Immunology, Inc. Dimero peptidico.
CA2631292C (en) 2005-11-30 2014-05-06 International Institute Of Cancer Immunology, Inc. Derivatised wt1 cancer antigen peptides and their use
US20070191271A1 (en) 2006-02-10 2007-08-16 Dow Pharmaceutical Sciences Method for stabilizing polypeptides lacking methionine
WO2009046369A2 (en) * 2007-10-05 2009-04-09 Medtronic, Inc. Use of a specific dosage regimen of ifn-alpha and ribavirin for treating hepatitis c
US8586706B2 (en) * 2007-10-25 2013-11-19 Kagoshima University Peptide vaccine using mimic molecules of amyloid β peptide
AR076349A1 (es) * 2009-04-23 2011-06-01 Int Inst Cancer Immunology Inc Peptido auxiliar del antigeno del cancer
US9539299B2 (en) * 2011-10-27 2017-01-10 International Institute Of Cancer Immunology, Inc. Combination therapy with WT1 peptide vaccine and temozolomide
EP2974734B1 (en) * 2013-03-12 2018-10-10 Sumitomo Dainippon Pharma Co., Ltd. Liquid aqueous composition
SG11201507883SA (en) * 2013-03-29 2015-10-29 Sumitomo Dainippon Pharma Co Ltd Wt1-antigen peptide conjugate vaccine

Similar Documents

Publication Publication Date Title
JP2020015742A5 (https=)
JP2016065060A5 (https=)
AU2015205567B2 (en) Flagellin-containing protein nanoparticles as a vaccine platform
US9102710B2 (en) Cyclic peptides binding CXCR4 receptor and relative medical and diagnostic uses
JP2016199557A5 (https=)
RU2017119773A (ru) Пептидные антагонисты пептидных гормонов из семейства кальцитонина (cgrp) и их применение
JP2017523959A (ja) ヘプシジンおよびミニ−ヘプシジンアナログおよびその使用
JP2016196472A5 (https=)
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
CN102300580A (zh) 二肽连接的药剂
JP6941143B2 (ja) 注射用医薬組成物
CN102812038A (zh) 胃肠道病症的治疗
RU2017146657A (ru) Пролекарства, содержащие коньюгат гиалуроновой кислоты, ликера и и двойного агониста glp-1глюкагона
JP7550762B2 (ja) リポペプチドビルディングブロックおよび合成ウイルス様粒子
EP3638284B1 (en) Cyclic peptides for protection against respiratory syncytial virus
JP2014508734A5 (https=)
JP2025169325A (ja) 結腸洗浄及び胃腸障害の治療のための組成物
WO2013133405A1 (ja) ペプチドを含む医薬組成物
JP2018511326A5 (https=)
JP2009500298A5 (https=)
EP2766384B1 (en) Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
HRP20140886T1 (hr) MUTANTI CyaA POLIPEPTIDI I POLIPEPTIDNI DERIVATI PRIKLADNI ZA DOPREMANJE IMUNOGENIÄŚNIH MOLEKULA U STANICU
JP6656661B2 (ja) プレキシンの結合調節剤
JP2004521911A (ja) 投薬方式
CN113939313B (zh) 以肽核酸为基础的佐剂